Erleada (apalutamide) – to treat men with cancer of the prostate (a gland of the male reproductive system).
Erleada is a cancer medicine that contains the active substance apalutamide. It is used to treat adult men with prostate cancer that:
- has not metastasised to other parts of the body and
- no longer responds to medical or surgical treatment that lowers testosterone (also called castration-resistant prostate cancer).
Erleada works by blocking the activity of hormones called androgens (such as testosterone).
Androgens can cause the cancer to grow. By blocking the effect of androgens, apalutamide stops
prostate cancer cells from growing and dividing.
NAME OF THE MEDICINAL PRODUCT
Erleada 60 mg film-coated tablets
STATEMENT OF ACTIVE SUBSTANCE(S)
Each film-coated tablet contains 60 mg apalutamide.
Film-coated tablet (tablet). Slightly yellowish to greyish green, oblong-shaped, film-coated tablets (16.7 mm long x 8.7 mm
wide), debossed with “AR 60” on one side.
METHOD AND ROUTE(S) OF ADMINISTRATION
Swallow the tablets whole.
Read the package leaflet before use.
Do not swallow or discard the desiccant.